位置:首页 > 蛋白库 > LAG3_RAT
LAG3_RAT
ID   LAG3_RAT                Reviewed;         525 AA.
AC   Q5BK54;
DT   17-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   12-APR-2005, sequence version 1.
DT   03-AUG-2022, entry version 113.
DE   RecName: Full=Lymphocyte activation gene 3 protein;
DE            Short=LAG-3;
DE   AltName: CD_antigen=CD223;
DE   Contains:
DE     RecName: Full=Secreted lymphocyte activation gene 3 protein {ECO:0000305};
DE              Short=sLAG-3 {ECO:0000250|UniProtKB:Q61790};
DE   Flags: Precursor;
GN   Name=Lag3;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Lewis.1W;
RA   Haudebourg T., Coulon F., Vanhove B.;
RT   "Coding sequence of rat LAG-3 (CD223), LEWIS.1W (RT1u) strain.";
RL   Submitted (MAR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Thymus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Lymphocyte activation gene 3 protein: Inhibitory receptor on
CC       antigen activated T-cells. Delivers inhibitory signals upon binding to
CC       ligands, such as FGL1. FGL1 constitutes a major ligand of LAG3 and is
CC       responsible for LAG3 T-cell inhibitory function. Following TCR
CC       engagement, LAG3 associates with CD3-TCR in the immunological synapse
CC       and directly inhibits T-cell activation. May inhibit antigen-specific
CC       T-cell activation in synergy with PDCD1/PD-1, possibly by acting as a
CC       coreceptor for PDCD1/PD-1. Negatively regulates the proliferation,
CC       activation, effector function and homeostasis of both CD8(+) and CD4(+)
CC       T-cells. Also mediates immune tolerance: constitutively expressed on a
CC       subset of regulatory T-cells (Tregs) and contributes to their
CC       suppressive function. Also acts as a negative regulator of plasmacytoid
CC       dendritic cell (pDCs) activation. Binds MHC class II (MHC-II); the
CC       precise role of MHC-II-binding is however unclear.
CC       {ECO:0000250|UniProtKB:Q61790}.
CC   -!- FUNCTION: [Secreted lymphocyte activation gene 3 protein]: May function
CC       as a ligand for MHC class II (MHC-II) on antigen-presenting cells
CC       (APC), promoting APC activation/maturation and driving Th1 immune
CC       response. {ECO:0000250|UniProtKB:Q61790}.
CC   -!- SUBUNIT: Interacts with MHC class II (MHC-II); selectively recognizes
CC       stable complexes of peptide and MHC-II. Interacts with FGL1 (via the
CC       Fibrinogen C-terminal domain). {ECO:0000250|UniProtKB:Q61790}.
CC   -!- SUBCELLULAR LOCATION: [Lymphocyte activation gene 3 protein]: Cell
CC       membrane {ECO:0000250|UniProtKB:Q61790}; Single-pass type I membrane
CC       protein {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: [Secreted lymphocyte activation gene 3 protein]:
CC       Secreted {ECO:0000250|UniProtKB:Q61790}. Note=Produced following
CC       cleavage of the main chain. {ECO:0000250|UniProtKB:Q61790}.
CC   -!- DOMAIN: [Lymphocyte activation gene 3 protein]: The KIEELE motif is
CC       required for interaction with downstream signaling molecules.
CC       {ECO:0000250|UniProtKB:Q61790}.
CC   -!- PTM: [Lymphocyte activation gene 3 protein]: Proteolytically cleaved by
CC       ADAM10 and ADAM17 within the connecting peptide region, leading to
CC       release of Secreted lymphocyte activation gene 3 protein (sLAG-3).
CC       ADAM10 mediates constitutive cleavage, but cleavage increases following
CC       T-cell activation, whereas shedding by ADAM17 is induced by TCR
CC       signaling in a PRKCQ-dependent manner. {ECO:0000250|UniProtKB:Q61790}.
CC   -!- SIMILARITY: Belongs to the LAG3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ438937; ABE68618.1; -; mRNA.
DR   EMBL; BC091201; AAH91201.1; -; mRNA.
DR   RefSeq; NP_997678.2; NM_212513.2.
DR   RefSeq; XP_008761504.1; XM_008763282.2.
DR   AlphaFoldDB; Q5BK54; -.
DR   STRING; 10116.ENSRNOP00000036771; -.
DR   GlyGen; Q5BK54; 3 sites.
DR   PaxDb; Q5BK54; -.
DR   PRIDE; Q5BK54; -.
DR   Ensembl; ENSRNOT00000028965; ENSRNOP00000036771; ENSRNOG00000021334.
DR   GeneID; 297596; -.
DR   KEGG; rno:297596; -.
DR   UCSC; RGD:1302990; rat.
DR   CTD; 3902; -.
DR   RGD; 1302990; Lag3.
DR   eggNOG; ENOG502S2HD; Eukaryota.
DR   GeneTree; ENSGT01050000244846; -.
DR   HOGENOM; CLU_041154_1_0_1; -.
DR   InParanoid; Q5BK54; -.
DR   OMA; LWVAPVE; -.
DR   OrthoDB; 862925at2759; -.
DR   PhylomeDB; Q5BK54; -.
DR   TreeFam; TF335942; -.
DR   Reactome; R-RNO-2132295; MHC class II antigen presentation.
DR   PRO; PR:Q5BK54; -.
DR   Proteomes; UP000002494; Chromosome 4.
DR   Bgee; ENSRNOG00000021334; Expressed in thymus and 14 other tissues.
DR   GO; GO:0009897; C:external side of plasma membrane; ISO:RGD.
DR   GO; GO:0005576; C:extracellular region; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042289; F:MHC class II protein binding; ISO:RGD.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISO:RGD.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0042267; P:natural killer cell mediated cytotoxicity; IEA:Ensembl.
DR   GO; GO:0032703; P:negative regulation of interleukin-2 production; ISO:RGD.
DR   GO; GO:0045590; P:negative regulation of regulatory T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0050868; P:negative regulation of T cell activation; ISO:RGD.
DR   GO; GO:0002270; P:plasmacytoid dendritic cell activation; ISS:UniProtKB.
DR   GO; GO:0045954; P:positive regulation of natural killer cell mediated cytotoxicity; ISO:RGD.
DR   GO; GO:0050776; P:regulation of immune response; ISS:UniProtKB.
DR   GO; GO:0042110; P:T cell activation; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 3.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR015621; IL-1_rcpt_fam.
DR   InterPro; IPR013151; Immunoglobulin.
DR   PANTHER; PTHR11890; PTHR11890; 1.
DR   Pfam; PF00047; ig; 2.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 2.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   2: Evidence at transcript level;
KW   Adaptive immunity; Cell membrane; Disulfide bond; Glycoprotein; Immunity;
KW   Immunoglobulin domain; Membrane; Reference proteome; Repeat; Secreted;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..23
FT                   /evidence="ECO:0000255"
FT   CHAIN           24..525
FT                   /note="Lymphocyte activation gene 3 protein"
FT                   /id="PRO_0000253042"
FT   CHAIN           24..?
FT                   /note="Secreted lymphocyte activation gene 3 protein"
FT                   /evidence="ECO:0000250|UniProtKB:Q61790"
FT                   /id="PRO_0000446644"
FT   TOPO_DOM        24..442
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        443..463
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        464..525
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          37..163
FT                   /note="Ig-like V-type"
FT   DOMAIN          164..246
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          258..341
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          345..412
FT                   /note="Ig-like C2-type 3"
FT   REGION          37..246
FT                   /note="Interaction with FGL1"
FT                   /evidence="ECO:0000250|UniProtKB:P18627"
FT   REGION          422..442
FT                   /note="Connecting peptide"
FT                   /evidence="ECO:0000250|UniProtKB:Q61790"
FT   REGION          483..525
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          493..522
FT                   /note="15 X 2 AA tandem repeats of E-X"
FT   MOTIF           490..495
FT                   /note="KIEELE motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q61790"
FT   COMPBIAS        498..515
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        184
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        244
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        309
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        44..156
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        185..235
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        276..327
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        363..405
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ   SEQUENCE   525 AA;  57988 MW;  13CA457327052C4E CRC64;
     MRQDLFLDLL LLQLLWEAPV VSSGPGKELS VVWAQEGAPV HLPCSLEFPH LDPNFLRRGW
     VTWQHRPDSD QPASIPALDL LQGMPSTRRH PPHRYTVLSV APGGLRSGRQ PLLSHVQLEK
     RGPQRGDFSL WLRPATRKDA GEYHAFVRLP DRDFSCSLRL RVGQASMIAS PPGTLKPSDW
     VILNCSFSRP DRPVSVHWFQ GQSRVPVHNS PRHYLAESFL LLPQVSPLDS GTWGCVLTYR
     DGFNVSITYN LKVQGLEPVA PLTVYAAEGS RVELPCHLPP VVGTPSLLIA KWTPPGGGPE
     LPVTGKSGNF TLQLENVGRA QAGTYTCSIH LQGRQLSAAV TLAVITVTPK SFGLPGSPQK
     LLCEVVPASG EGRFVWRPLS DLSRSSLGPV LELQEAKLLA EQWQCQLYEG QKLLGATVYT
     AESSSGAWSA KRISGDLKGG HLFLSLILGA LALFLLVTGA FGFHLWRRQL LRRRFSALEH
     GIRPPPVQSK IEELEREPET EMEPETEPDP EPQPEPELEP ESRQL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024